Free Trial

Vanda Pharmaceuticals (VNDA) SEC Filings & 10K Form

Vanda Pharmaceuticals logo
$4.44 -0.07 (-1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$4.43 -0.01 (-0.11%)
As of 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vanda Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/25/2025
3:31 PM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
04/15/2025
4:04 PM
BlackRock Portfolio Management LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SCHEDULE 13G
03/17/2025
8:15 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
4:53 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:45 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:44 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:45 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:30 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:13 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:38 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:04 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
7:21 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:44 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:44 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:45 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:46 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
12:40 PM
BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/27/2025
7:22 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:45 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:07 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
7:00 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:00 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:10 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:47 AM
Vanda Pharmaceuticals (Filer)
Form 8-A12B/A
08/08/2024
6:29 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:05 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
4:21 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
4:24 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:38 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:30 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:43 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:49 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
3:52 PM
Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:53 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:53 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
05/21/2024
3:55 PM
Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:34 PM
Vanda Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
4:26 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:15 PM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
05/09/2024
6:07 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:51 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VNDA) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners